us en false false Default
Skip directly to Accessibility Notice
TRUH VanEck Healthcare TruSector ETF Please read important disclosure Close important disclosure Show More Show Less Compare false

TRUH
VanEck Healthcare TruSector ETF

TRUH
VanEck Healthcare TruSector ETF

  • NAV
    $31.60

    as of October 22, 2026
  • Performance since inception
    23.63%

    as of October 22, 2026
  • Total Net Assets
    $632.01K

    as of October 22, 2026
  • Total Expense Ratio
    0.10%
  • Inception Date
    04/01/2026

Overview

Why TRUH

  • Full Market Cap Sector ExposureProvides comprehensive market capitalization exposure to healthcare stocks unlike many traditional sector ETFs
  • Reduced Benchmark DeviationAvoids persistent underweighting of largest sector constituents that may cause performance drift
  • Precision Sector Allocation ToolDesigned to help asset allocators track sector benchmarks with greater accuracy

About TRUH

VanEck Healthcare TruSector ETF (the “Fund”) is an actively managed ETF that seeks long-term capital appreciation by investing in securities of healthcare-related companies or instruments that provide exposure to healthcare-related companies.

Performance

Average Annual Total Returns* (%)

  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
04/01/26
TRUH (NAV) -0.89 6.44 -- -- -- -- -- 14.79
TRUH (Market Price) -0.70 6.77 -- -- -- -- -- 15.13
MarketVector Top US Health Care Companies Index -0.91 6.17 -- -- -- -- -- 14.34
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
04/01/26
TRUH (NAV) -0.89 6.44 -- -- -- -- -- 14.79
TRUH (Market Price) -0.70 6.77 -- -- -- -- -- 15.13
MarketVector Top US Health Care Companies Index -0.91 6.17 -- -- -- -- -- 14.34

Holdings

Daily Holdings (%) as of 10/22/2026

Download XLS Get holdings
Total Holdings: 62
Ticker
Holding Name % of Net
Assets
Market Value
(US$)
LLY
Eli Lilly & Co 15.92 100,615
JNJ
Johnson & Johnson 9.82 62,086
ABBV
Abbvie Inc 7.67 48,482
UNH
Unitedhealth Group Inc 5.78 36,548
MRK
Merck & Co Inc 5.52 34,896
TMO
Thermo Fisher Scientific Inc 3.85 24,355
AMGN
Amgen Inc 3.68 23,259
GILD
Gilead Sciences Inc 2.96 18,706
ABT
Abbott Laboratories 2.69 17,017
PFE
Pfizer Inc 2.64 16,670
ISRG
Intuitive Surgical Inc 2.39 15,091
DHR
Danaher Corp 2.18 13,785
VRTX
Vertex Pharmaceuticals Inc 2.03 12,844
BMY
Bristol-Myers Squibb Co 1.95 12,348
MDT
Medtronic Plc 1.88 11,881
CVS
Cvs Health Corp 1.84 11,621
MCK
Mckesson Corp 1.76 11,136
SYK
Stryker Corp 1.65 10,441
ELV
Elevance Health Inc 1.48 9,351
CI
Cigna Group/The 1.25 7,897
REGN
Regeneron Pharmaceuticals Inc 1.17 7,372
MRNA
Moderna Inc 1.15 7,295
HCA
Hca Healthcare Inc 1.04 6,542
BSX
Boston Scientific Corp 1.01 6,395
COR
Cencora Inc 0.96 6,093
CAH
Cardinal Health Inc 0.89 5,624
BDX
Becton Dickinson & Co 0.82 5,211
HUM
Humana Inc 0.80 5,052
EW
Edwards Lifesciences Corp 0.78 4,955
A
Agilent Technologies Inc 0.74 4,695
IDXX
Idexx Laboratories Inc 0.72 4,534
VEEV
Veeva Systems Inc 0.71 4,516
IQV
Iqvia Holdings Inc 0.70 4,453
WAT
Waters Corp 0.65 4,100
ILMN
Illumina Inc 0.64 4,041
BIIB
Biogen Inc 0.56 3,554
RMD
Resmed Inc 0.56 3,543
MTD
Mettler-Toledo International Inc 0.53 3,369
CNC
Centene Corp 0.53 3,348
ZTS
Zoetis Inc 0.52 3,280
GEHC
Ge Healthcare Technologies Inc 0.49 3,069
DXCM
Dexcom Inc 0.45 2,820
WST
West Pharmaceutical Services Inc 0.44 2,758
DGX
Quest Diagnostics Inc 0.42 2,676
LH
Labcorp Holdings Inc 0.42 2,639
STE
Steris Plc 0.33 2,090
VTRS
Viatris Inc 0.32 2,033
INCY
Incyte Corp 0.30 1,871
ZBH
Zimmer Biomet Holdings Inc 0.28 1,779
RVTY
Revvity Inc 0.27 1,730
CRL
Charles River Laboratories Internationa 0.27 1,698
BAX
Baxter International Inc 0.20 1,283
SOLV
Solventum Corp 0.19 1,224
COO
Cooper Cos Inc/The 0.19 1,171
TECH
Bio-Techne Corp 0.17 1,089
PODD
Insulet Corp 0.16 1,037
UHS
Universal Health Services Inc 0.15 941
ALGN
Align Technology Inc 0.15 933
HSIC
Henry Schein Inc 0.12 774
DVA
Davita Inc 0.09 558
2602335D
Tpg Inc 0.00 0
-USD CASH-
-- 0.03 201
--
Other/Cash 0.10 635
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Fees

Distributions

  as of  10/22/2026


Distribution Frequency

Quarterly


30-Day SEC Yield

1.38%


Distribution Yield

1.65%


12 Month Yield

--

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Healthcare TruSector ETF would have been 1.38% on 10/22/26. Distributions may vary from time to time.

Distribution History

Year Ex-date Record Date Payable date Dividend
Income‡
Short-Term
Capital Gains
Long-Term
Capital Gains
Return of
Capital
Total
Distributions
2026 10/01/2026 10/01/2026 10/06/2026 $ 0.1301 -- -- -- $ 0.13
2026 07/01/2026 07/01/2026 07/07/2026 $ 0.0847 -- -- -- $ 0.08

‡All registered investment companies are obliged to distribute portfolio gains to shareholders at yearend regardless of performance. Trading VanEck ETFs will also generate tax consequences and transaction expenses. The information provided is not intended to be tax advice. Tax consequences of dividend distributions may vary by individual taxpayer. There is no guarantee that dividends will be paid. To receive a distribution, you must have been a registered shareholder of the relevant VanEck ETFs on the record date. Distributions are paid to shareholders on the payment date. Past distributions are not indicative of future distributions.

Certain distributions may constitute a return of capital, which will have the effect of reducing your cost basis in the Fund’s shares and thereby increasing the amount of capital gain, if any, or decreasing the amount of capital loss, if any, that you will realize when selling or exchanging Fund shares. The final determination of the tax characteristics cannot be determined until after each Fund’s yearend and are reported to shareholders on Form 1099-DIV. The form is mailed to shareholders shortly after calendar yearend specifying how the distributions paid by the Fund during the prior calendar year should be characterized for purposes of reporting the distribution on a shareholder’s tax return.

The tax treatment and characterization of the Fund’s distributions may vary significantly from time to time depending on whether the Fund has gains or losses on the securities in its portfolio. The Fund’s distributions will normally reflect past and projected net investment income, and may include income from dividends and interest, capital gains and/or a return of capital. The final composition of the tax characteristics of the distributions cannot be determined with certainty until after the end of the year, and will be reported to shareholders at that time. The amount of distributions will vary, depending on a number of factors. As portfolio and market conditions change, the rate of dividends may change. There can be no assurance that the Fund will be able to declare a dividend distribution in each period. Past performance is no guarantee of future results.

Click here to access more detailed yearend tax information

Team

Resources

Regulatory Information

Thought Leadership

TRUH